Eli Lilly Gets CDSCO Panel Nod To Import, Market Anti-cancer Drug Selpercatinib Dr. Divya Colin9 April 2024 6:00 PM ISTNew Delhi: Advising to conduct the Phase IV clinical trial, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO Panel Approves Novo Nordisk's Protocol Amendment Proposal for CagriSema Study Dr. Divya Colin9 April 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major Novo...
Sun Pharmaceutical Industries Gets CDSCO Panel Nod to Study FDC of Relugolix, Estradiol, Norethindrone Acetate Dr. Divya Colin8 April 2024 6:00 PM ISTNew Delhi: Rejecting for clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
Eli Lilly Gets CDSCO Panel Nod To Market Mirikizumab for ulcerative colitis in adults Dr. Divya Colin7 April 2024 6:00 PM ISTNew Delhi: Pharmaceutical major Eli Lilly has got marketing authorization from the Subject Expert Committee (SEC) functional under the Central Drug...
Exemed Pharmaceutical Gets CDSCO Panel Nod to Study Empagliflozin plus Glimepiride plus Metformin FDC Dr. Divya Colin7 April 2024 5:00 PM ISTNew Delhi: Exemed Pharmaceutical has got approval from the Subject Expert Committee SEC functional under the Central Drug Standard Control...
Sun Pharma Industries Gets CDSCO Panel Nod To Manufacture Market Elagolix Tablets 150 mg,200 mg Dr. Divya Colin6 April 2024 6:00 PM ISTNew Delhi: With the condition to be sold by retail under the prescription of a Gynaecologist only, pharmaceutical major Sun Pharma Industries has got...
CDSCO Panel Approves AstraZeneca's Protocol Amendment Proposal For COPD Drug Study Dr. Divya Colin5 April 2024 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
Atleast 50% more geographically distributed Govt sites be included: CDSCO panel Tells IQVIA in Milvexian study Dr. Divya Colin3 April 2024 6:00 PM ISTNew Delhi: Reviewing the proposal presented by IQVIA regarding the waiving of the specific condition in the Milvexian study, the Subject Expert...
Not approved as Inhalation suspension for nebulization, Conduct CT: CDSCO Panel Tells Glenmark on Pulmonary FDC Dr. Divya Colin2 April 2024 6:00 PM ISTNew Delhi: Noting that the proposed fixed-dose combination (FDC) of Glycopyrrolate plus Formoterol Fumarate Dihydrate plus Budesonide (25mcg+20mcg+500...
Drug safety alert: CDSCO flags 58 drug samples Roshni Dhar2 April 2024 5:06 PM ISTIn its latest drug safety alert, the apex drug regulatory body, the Central Standard Control Organisation (CDSCO) has flagged 58 medicine batches for...
Health Bulletin 02/ April/ 2024 Roshni Dhar2 April 2024 4:57 PM ISTHere are the top health stories for the day:CDSCO issues alert for 58 drug samplesIn its latest drug safety alert, the apex drug regulatory body, the...
CDSCO Panel grants Novo Nordisk's Protocol Amendment Proposal For Antidiabetic Drug Semaglutide study Dr. Divya Colin31 March 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major Novo...
